Navigation Links
New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study
Date:10/6/2008

, Centre Hospitalier Universitaire Lille, France and lead investigator. "These data reinforce the efficacy and safety profile of REMICADE in the treatment of this chronic inflammatory bowel disease."

Dr. William J. Sandborn, Inflammatory Bowel Disease Clinic, Mayo Clinic, and principal investigator for the SONIC trial will present the results of the SONIC trial on Tuesday, October 7 at the annual meeting of the American College of Gastroenterology.

The SONIC clinical trial, the first of its kind to compare REMICADE, an anti-tumor necrosis factor (TNF)-alpha therapy, with an immunomodulator in patients with moderate to severe Crohn's disease previously failing 5-aminosalicylate (5-ASA) and/or steroids, included more than 500 subjects from clinics across the United States, Europe and Israel. In addition to improved rates of steroid-free remission in patients receiving REMICADE, the data showed that a greater proportion of patients with Crohn's disease achieved mucosal healing, a secondary endpoint of the study, when receiving REMICADE. Results from SONIC revealed that 44 percent of patients receiving REMICADE combination therapy and 30 percent receiving REMICADE monotherapy achieved mucosal healing compared with 17 percent of patients receiving azathioprine alone (P < 0.001 REMICADE with azathioprine vs. azathioprine monotherapy; P = 0.023 REMICADE monotherapy vs. azathioprine monotherapy; P = 0.055 REMICADE with azathioprine vs. REMICADE monotherapy).

The data also showed that the safety profile of REMICADE in combination or as monotherapy was similar to that of azathioprine monotherapy in the study. At week 30, 24 percent of patients receiving azathioprine monotherapy experienced one or more serious adverse events compared with 16 and 14 percent of patients receiving REMICADE monotherapy and REMICADE with azathioprine, respectively. That includes 2 patients receiving azathioprine monotherapy who developed colon cancer, one patient receiving azat
'/>"/>

SOURCE Centocor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. More Findings on Gene Involved in Childhood Asthma
2. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
3. VAI Findings Could Aid Diagnosis and Treatment of Several Types of Kidney Cancer
4. Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention
5. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
6. FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
7. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
8. Study Findings Show Infection Control Intervention Helps Keep Kids in School
9. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
10. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
11. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... SHENZHEN, China, Nov. 26, 2014 China Nepstar ... the "Company"), a leading retail drugstore chain in China ... announced its unaudited financial results for the third quarter ... ended September 30, 2014: , Same store sales increased ... , Revenue increased by 8.1% to RMB738.3 million (US$120.3 ...
(Date:11/24/2014)... , Nov. 24, 2014 Luoxis Diagnostics, ... MKT: AMPE), today announced the presentation of three ... System as a broadly applicable and robust research ... the body in response to injury, illness, or ... in collaboration with Luoxis, academic and pharmaceutical research ...
(Date:11/24/2014)... CLEVELAND , Nov. 24, 2014  Surgical Theater, ... at the November 24 th opening of ... IRCCS Istituto Neurologico Nazionale "C. Besta." The SuRgical Planner ... be showcased at the event for their 3D navigation ... Dr. Joshua Bederson , Professor and Chair, Department ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 2Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 4Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 5Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 3
... 20, 2011 Robbins & Myers, Inc. (NYSE: ... first quarter fiscal 2012 ending November 30, 2011 before the ... 9:00 a.m., CT / 10:00 a.m., ET on January 6.  ... J. Brown, Interim Chief Financial Officer & Corporate Controller, will ...
... HACKENSACK, N.J., Dec. 20, 2011 In an ... error rates, HackensackUMC recently announced the implementation of ... SurgiCount Safety-Sponge®  is a product of SurgiCount Medical, ... Technologies, Inc. (OTCBB:PSTX, OTCQB:PSTX). This system provides a ...
Cached Medicine Technology:HackensackUMC Adopts SurgiCount Safety-Sponge® System 2HackensackUMC Adopts SurgiCount Safety-Sponge® System 3
(Date:11/26/2014)... Obispo, CA (PRWEB) November 26, 2014 ... is offering lower prices in an early celebration of ... Bunion Booties are being offered at the promotional price ... promotional pricing is in addition to any automatic discounts ... the Bunion Bootie website for complete details. ...
(Date:11/26/2014)... Rouge, Louisiana (PRWEB) November 26, 2014 ... neck pain relief and specialists in minimally invasive ... K. Samer Shamieh into the rapidly growing provider ... specialists. The addition coincides with the network’s ... reliable medical treatment for Louisiana residents who are ...
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, Jennifer ... Preceptorship Award from The American Association of ... advancement of nurse practitioners. The Distinguished Preceptorship Award ... made a significant contribution toward increasing the awareness ... Nurse Practitioners (AANP) is the largest full-service national ...
(Date:11/26/2014)... -- Youngsters who enter puberty early are at increased ... puberty was linked with a number of factors associated ... levels, according to the researchers. Early puberty was also ... and peers, and having friends who were prone to ... study found an association between early puberty and these ...
(Date:11/26/2014)... Nov. 25, 2014 (HealthDay News) -- Teens prescribed ... to abuse those drugs than other teens, a ... need to conduct substance abuse assessments on teenagers ... said. "Prescribers and parents don,t realize the ... professor at the University of Michigan School of ...
Breaking Medicine News(10 mins):Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2
... Rheumatoid arthritis is an autoimmune disease that most often affects ... the immune system to attack the joints, which can cause ... Methotrexate is the standard drug used to treat the condition, ... to toxicity.// , , Patients taking ...
... to establish whether people who exercise can improve their health or ... , Consensus statements published ... exercise improve their health.// But researchers often can't tell how much ... even if a workout will make a difference at all. ...
... of a medical check. Generally, it is assumed that high ... and low density lipoprotein (LDL, or 'bad' cholesterol) low. ... At Johns Hopkins University in the US, researchers believe that ... the difference between total cholesterol and HDL. It is the ...
... can be used to kill the deadly Hepatitis E virus has ... viral clones and would kill the virus by cutting RNA. ... being tested on animals. The cloned virus could also be used ... , , For this, the ...
... tomato products, such as tomato sauce and ketchup, have long ... prostate cancer, but the reason for such an action is ... lycopene, which is found in tomato products and other natural ... treating the disease in its earliest stages.// ,Dr. ...
... E Merck has launched Livogen Z, in the market with ... the trademark haematinic drug Livogen.Livogen was an old product of ... sold its Livogen brand to E Merck India Ltd. ... Stock Exchange (BSE), Glaxo India signed a memorandum of understanding ...
Cached Medicine News:Health News:How much can exercise improve health? 2Health News:Protective effects of tomatoes in prostate cancer 2
... The VASER System represents a ... ultrasonic technology to cosmetic procedures. Combined ... selective tissue emulsification, a solid grooved ... the VASER System has been designed ...
... The next generation of the ... PSI-TEC III retains all the ... PSI-TEC a leading name for,aspiration ... flow,vacuum pumps for high powered ...
Richardson Retractor...
Our most popular saline breast implant style for over 20 years. A full, rounded look that adds greater dimension to the breast....
Medicine Products: